SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : CMGI What is the latest news on this stock? -- Ignore unavailable to you. Want to Upgrade?


To: HG who wrote (5486)3/10/1999 2:34:00 AM
From: neverenough  Respond to of 19700
 
Thought this was rather interesting, Intel is the second largest institutional owner of CMGI as of the first of the year. Over 2 million shares.

CMGI Inc.
NASD : CMGI
Sector: Financial
Industry: Misc. Financial Services



Top Five Institutional Holders
Rank Institutional Name Report Date Position
1 FMR CORPORATION (FIDELITY MANAGEMENT & RESEARCH CORP) 12/31/98 4,180,000
2 INTEL CORPORATION 12/31/98 2,012,008
3 GRUBER & MCBAINE CAPITAL MANAGEMENT 12/31/98 1,352,250
4 SCUDDER KEMPER INVESTMENTS, INC. 12/31/98 1,143,844
5 CITIGROUP INC. 12/31/98 1,103,456


Glossary of financial terms.







To: HG who wrote (5486)3/10/1999 9:49:00 AM
From: badon518  Read Replies (2) | Respond to of 19700
 
funny you should mention that. yes, i did have to invest a (large) chunk of my inheritance in a zillion shares of dmph (domestic peace and harmony). i already have a substantial stake in dmph to the point where it literally affects my entire life. it doesn't lend itself either to day trading or to short selling. so when the "opportunity" came to invest more, well, i couldn't easilt refuse. my post was probably ambiguous about what i did with the leftovers. none of it is going into critical path, although i've got some other funds to play aorund with. i have put a chunk of the residue in cmgi, and for now the rest in cash until i find some other companies that i like and understand (i'm looking at biotechs that specialize in gene therapies, they all look promising but then you see where their products are and where they're not and suddenly it looks dimmer. it's that darn level III testing that gets them every time. but i'm still learning over there. sorry this is so long. eom